RELATIONSHIP BETWEEN PLASMA ATRIAL-NATRIURETIC-FACTOR AND URINARY KALLIKREIN EXCRETION IN ESSENTIAL HYPERTENSIVES

被引:2
作者
DESSIFULGHERI, P
DINOTO, G
PALERMO, R
CATALINI, R
RUSSO, P
RAPPELLI, A
机构
[1] Istituto di Patologia Medica, University of Ancona
关键词
ATRIAL NATRIURETIC FACTOR; URINARY KALLIKREIN; BLOOD PRESSURE; SODIUM BALANCE; RENINANGIOTENSIN SYSTEM;
D O I
10.1093/ajh/4.3.214
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
In order to seek possible relationships between renal kallikrein and atrial natriuretic factor (ANF), we measured urinary kallikrein (UK) and ANF in 84 normal subjects (NS) and in 104 uncomplicated essential hypertensives (HP). Atrial natriuretic factor was significantly higher in HP than in NS (38.5 +/- 1.3 v 29.0 +/- 1.3 pg/mL, P < .01), whereas UK was significantly lower in HP than in NS (11.1 +/- 0.9 v 15.3 +/- 0.6 nkatal/24 h, P < .01). Calculating the 95% of the percentile distribution of the single values of UK in the group of NS we were able to show that 24 out of 104 HP had a UK which fell below the lowest limit (4.5 nkat/24 h) of the normal range. We therefore divided our HP into two subgroups: patients with normal kallikrein excretion (NK) (n = 80; mean UK 13.8 +/- 0.8 nkat/24 h) and patients with low kallikrein excretion (LK) (n = 24; mean UK 2.3 +/- 0.3 nkat/24 h). Normal kallikrein patients had a mean plasma ANF value of 31.9 +/- 1.2 pg/mL which was almost superimposable to that found in NS; on the contrary, the mean plasma level of ANF in LK patients (50.7 +/- 2.2 pg/mL) was significantly higher than that measured in NK patients and in NS (P < .01 v NK patients and NS, respectively). Since a low urinary kallikrein excretion may represent a marker of an impaired production of renal kallikrein, the high levels of ANF found in the LK subgroup could be the result of a compensatory response of the atrium attempting to maintain sodium and volume homeostasis.
引用
收藏
页码:214 / 218
页数:5
相关论文
共 25 条
[1]  
Margolius H.S., Geller R., Pisano J.J., Sjoerdema A., Altered urinary kallikrein excretion in human hypertension, Lancet, 2, pp. 1063-1065, (1971)
[2]  
Ura N., Shimamoto K., Nakao T., Et al., The excretion of human urinary kallikrein quantity and activity in normal and low renin subgroups of essential hypertension, Clin Exp Hypertens, A5, pp. 329-337, (1983)
[3]  
Madeddu P., Dessi-Fulgheri P., Oppes M., Et al., Blunted activation of prekallikrein in essential hypertensives and in patients with renal artery stenosis, Renovascular Hypertension, pp. 61-74, (1987)
[4]  
Marin-Grez M., Schaechtelin G., Bonner G., Et al., Renal kallikrein activity and urinary kallikrein excretion in rats with experimental renal hypertension, Clin Sci, 63, pp. 349-354, (1982)
[5]  
Ader J.L., Pollock D.M., Butterfield M.I., Arendshorst W.J., Abnormalities in kallikrein excretion in spontaneously hypertensive rats, Am J Physiol, 248, pp. F396-F403, (1985)
[6]  
Garcia R., Thibault G., Hamet P., Et al., Effects of atrial natriuretic factor [ANF (Arg 101-Tyr 126)] on kallikrein and cyclic GMP in the renovascular hypertensive rat, Clin Exp Hypertens, A7, pp. 1597-1618, (1985)
[7]  
Carretero O.A., Scicli A., Possible role of kinins in circulatory homeostasis, Hypertension, 3, pp. II4-I12, (1981)
[8]  
Debold A.J., Borenstein H.B., Veress A.T., Sonnenberg A., A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats, Life Sci, 28, pp. 89-94, (1981)
[9]  
Cantin M., Genest J., The heart and the atrial natriuretic factor, Endocrinol Rev, 6, pp. 107-127, (1985)
[10]  
Macdonald T.M., Jeffrey R.F., Lee M.R., Atrial natriuretic peptides in essential hypertension (Letter to the editor), Lancet, 1, (1986)